Different parvalbumin and GABA expression in human epileptogenic focal cortical dysplasia

Valentina Medici, Laura Rossini, Francesco Deleo, Giovanni Tringali, Laura Tassi, Francesco Cardinale, Manuela Bramerio, Marco de Curtis, Rita Garbelli, Roberto Spreafico

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Several studies have reported that inhibitory networks are altered in dysplastic tissue obtained from epilepsy surgery specimens. A consistent decrease in the number of inhibitory interneuronal subpopulation that expresses parvalbumin (PV) was reported in postsurgical tissue from patients with focal cortical dysplasia (FCD). We tested if the decrease in PV protein expression observed in epileptic tissue corresponds to a parallel impairment in the γ-aminobutyric acid (GABA)ergic compartment. Methods: We analyzed postsurgical tissue from 30 surgically treated patients who underwent surgery for intractable epilepsy including 26 patients with FCD (types I, II, and III) and 4 patients without any microscopic visible lesion (cryptogenic) as controls. Serial sections were processed using in situ hybridization with GAD-65 and GAD-67 probes and immunocytochemistry with antibody against PV. The density of inhibitory PV-immunoreactive interneurons in relation to GABAergic cells was estimated in controls and in all different pathologic groups by using a two- and three-dimensional (2D and 3D) cell-counting technique. Field fraction and line profile analyses were added to estimate immunostaining proportion and distribution of PV signal generated in gray matter. Results: A reduction of PV-positive cells and PV-immunoreactivity was observed exclusively in FCD type I/III specimens compared with cryptogenic tissue from control patients with a poor postsurgical outcome. In FCD type II, a profound rearrangement in the cortical distribution of PV immunoreactivity was observed, without a quantitative reduction of the number of neurons and terminals. In situ hybridization did not reveal significant variations of GAD expression in any FCD subtype. Significance: Our study suggests a preservation of inhibitory networks in FCD postsurgical tissue, demonstrated by a substantial normal count of GABAergic neurons. A selective PV expression impairment is demonstrated in FCD type I and III and an abnormal, but not reduced, distribution of PV cells and terminals is confirmed in type II FCD. Possible functional consequences are discussed.

Original languageEnglish
Pages (from-to)1109-1119
Number of pages11
JournalEpilepsia
Volume57
Issue number7
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

Malformations of Cortical Development
Parvalbumins
gamma-Aminobutyric Acid
In Situ Hybridization
Aminobutyrates
GABAergic Neurons
Interneurons
Epilepsy
Immunohistochemistry
Neurons

Keywords

  • Epilepsy
  • GAD-65/67 riboprobes
  • Immunohistochemistry
  • Inhibitory network

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Different parvalbumin and GABA expression in human epileptogenic focal cortical dysplasia. / Medici, Valentina; Rossini, Laura; Deleo, Francesco; Tringali, Giovanni; Tassi, Laura; Cardinale, Francesco; Bramerio, Manuela; de Curtis, Marco; Garbelli, Rita; Spreafico, Roberto.

In: Epilepsia, Vol. 57, No. 7, 01.07.2016, p. 1109-1119.

Research output: Contribution to journalArticle

Medici, Valentina ; Rossini, Laura ; Deleo, Francesco ; Tringali, Giovanni ; Tassi, Laura ; Cardinale, Francesco ; Bramerio, Manuela ; de Curtis, Marco ; Garbelli, Rita ; Spreafico, Roberto. / Different parvalbumin and GABA expression in human epileptogenic focal cortical dysplasia. In: Epilepsia. 2016 ; Vol. 57, No. 7. pp. 1109-1119.
@article{2468d66e7f2c4b8f8c750d082ea03043,
title = "Different parvalbumin and GABA expression in human epileptogenic focal cortical dysplasia",
abstract = "Objective: Several studies have reported that inhibitory networks are altered in dysplastic tissue obtained from epilepsy surgery specimens. A consistent decrease in the number of inhibitory interneuronal subpopulation that expresses parvalbumin (PV) was reported in postsurgical tissue from patients with focal cortical dysplasia (FCD). We tested if the decrease in PV protein expression observed in epileptic tissue corresponds to a parallel impairment in the γ-aminobutyric acid (GABA)ergic compartment. Methods: We analyzed postsurgical tissue from 30 surgically treated patients who underwent surgery for intractable epilepsy including 26 patients with FCD (types I, II, and III) and 4 patients without any microscopic visible lesion (cryptogenic) as controls. Serial sections were processed using in situ hybridization with GAD-65 and GAD-67 probes and immunocytochemistry with antibody against PV. The density of inhibitory PV-immunoreactive interneurons in relation to GABAergic cells was estimated in controls and in all different pathologic groups by using a two- and three-dimensional (2D and 3D) cell-counting technique. Field fraction and line profile analyses were added to estimate immunostaining proportion and distribution of PV signal generated in gray matter. Results: A reduction of PV-positive cells and PV-immunoreactivity was observed exclusively in FCD type I/III specimens compared with cryptogenic tissue from control patients with a poor postsurgical outcome. In FCD type II, a profound rearrangement in the cortical distribution of PV immunoreactivity was observed, without a quantitative reduction of the number of neurons and terminals. In situ hybridization did not reveal significant variations of GAD expression in any FCD subtype. Significance: Our study suggests a preservation of inhibitory networks in FCD postsurgical tissue, demonstrated by a substantial normal count of GABAergic neurons. A selective PV expression impairment is demonstrated in FCD type I and III and an abnormal, but not reduced, distribution of PV cells and terminals is confirmed in type II FCD. Possible functional consequences are discussed.",
keywords = "Epilepsy, GAD-65/67 riboprobes, Immunohistochemistry, Inhibitory network",
author = "Valentina Medici and Laura Rossini and Francesco Deleo and Giovanni Tringali and Laura Tassi and Francesco Cardinale and Manuela Bramerio and {de Curtis}, Marco and Rita Garbelli and Roberto Spreafico",
year = "2016",
month = "7",
day = "1",
doi = "10.1111/epi.13405",
language = "English",
volume = "57",
pages = "1109--1119",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Blackwell Publishing Inc.",
number = "7",

}

TY - JOUR

T1 - Different parvalbumin and GABA expression in human epileptogenic focal cortical dysplasia

AU - Medici, Valentina

AU - Rossini, Laura

AU - Deleo, Francesco

AU - Tringali, Giovanni

AU - Tassi, Laura

AU - Cardinale, Francesco

AU - Bramerio, Manuela

AU - de Curtis, Marco

AU - Garbelli, Rita

AU - Spreafico, Roberto

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Objective: Several studies have reported that inhibitory networks are altered in dysplastic tissue obtained from epilepsy surgery specimens. A consistent decrease in the number of inhibitory interneuronal subpopulation that expresses parvalbumin (PV) was reported in postsurgical tissue from patients with focal cortical dysplasia (FCD). We tested if the decrease in PV protein expression observed in epileptic tissue corresponds to a parallel impairment in the γ-aminobutyric acid (GABA)ergic compartment. Methods: We analyzed postsurgical tissue from 30 surgically treated patients who underwent surgery for intractable epilepsy including 26 patients with FCD (types I, II, and III) and 4 patients without any microscopic visible lesion (cryptogenic) as controls. Serial sections were processed using in situ hybridization with GAD-65 and GAD-67 probes and immunocytochemistry with antibody against PV. The density of inhibitory PV-immunoreactive interneurons in relation to GABAergic cells was estimated in controls and in all different pathologic groups by using a two- and three-dimensional (2D and 3D) cell-counting technique. Field fraction and line profile analyses were added to estimate immunostaining proportion and distribution of PV signal generated in gray matter. Results: A reduction of PV-positive cells and PV-immunoreactivity was observed exclusively in FCD type I/III specimens compared with cryptogenic tissue from control patients with a poor postsurgical outcome. In FCD type II, a profound rearrangement in the cortical distribution of PV immunoreactivity was observed, without a quantitative reduction of the number of neurons and terminals. In situ hybridization did not reveal significant variations of GAD expression in any FCD subtype. Significance: Our study suggests a preservation of inhibitory networks in FCD postsurgical tissue, demonstrated by a substantial normal count of GABAergic neurons. A selective PV expression impairment is demonstrated in FCD type I and III and an abnormal, but not reduced, distribution of PV cells and terminals is confirmed in type II FCD. Possible functional consequences are discussed.

AB - Objective: Several studies have reported that inhibitory networks are altered in dysplastic tissue obtained from epilepsy surgery specimens. A consistent decrease in the number of inhibitory interneuronal subpopulation that expresses parvalbumin (PV) was reported in postsurgical tissue from patients with focal cortical dysplasia (FCD). We tested if the decrease in PV protein expression observed in epileptic tissue corresponds to a parallel impairment in the γ-aminobutyric acid (GABA)ergic compartment. Methods: We analyzed postsurgical tissue from 30 surgically treated patients who underwent surgery for intractable epilepsy including 26 patients with FCD (types I, II, and III) and 4 patients without any microscopic visible lesion (cryptogenic) as controls. Serial sections were processed using in situ hybridization with GAD-65 and GAD-67 probes and immunocytochemistry with antibody against PV. The density of inhibitory PV-immunoreactive interneurons in relation to GABAergic cells was estimated in controls and in all different pathologic groups by using a two- and three-dimensional (2D and 3D) cell-counting technique. Field fraction and line profile analyses were added to estimate immunostaining proportion and distribution of PV signal generated in gray matter. Results: A reduction of PV-positive cells and PV-immunoreactivity was observed exclusively in FCD type I/III specimens compared with cryptogenic tissue from control patients with a poor postsurgical outcome. In FCD type II, a profound rearrangement in the cortical distribution of PV immunoreactivity was observed, without a quantitative reduction of the number of neurons and terminals. In situ hybridization did not reveal significant variations of GAD expression in any FCD subtype. Significance: Our study suggests a preservation of inhibitory networks in FCD postsurgical tissue, demonstrated by a substantial normal count of GABAergic neurons. A selective PV expression impairment is demonstrated in FCD type I and III and an abnormal, but not reduced, distribution of PV cells and terminals is confirmed in type II FCD. Possible functional consequences are discussed.

KW - Epilepsy

KW - GAD-65/67 riboprobes

KW - Immunohistochemistry

KW - Inhibitory network

UR - http://www.scopus.com/inward/record.url?scp=84977580532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977580532&partnerID=8YFLogxK

U2 - 10.1111/epi.13405

DO - 10.1111/epi.13405

M3 - Article

VL - 57

SP - 1109

EP - 1119

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 7

ER -